All News

In our final recipe in the Cooking with CURE series, our oncology dietitian friends at the John Theurer Cancer Center provide an interesting twist on the classic hummus recipe.

Heightening the dose of the targeted drug Rituxan (rituximab) during the first four cycles of the R-CHOP regimen does not improve outcomes in treating patients with diffuse large B-cell lymphoma, the phase 3 HOVON-84 trial found.

An early phase 1b/2 study of Copiktra in combination of standard of care shows how the treatment is active for patients with chronic lymphocytic leukemia but further study is needed to ensure it is an effective and safe alternative to standard of care.

As the COVID-19 pandemic continues to impact the care of patients with metastatic renal cell carcinoma and other cancers, health care professionals are working together to stay vigilant and make the best treatment decisions for their patients by pooling their data with tools like the COVID-19 and Cancer Consortium, says Dr. Toni K. Choueiri.

“Moving forward, (bendamustine and Rituxan) will likely become a common backbone for the incorporation of other cytotoxic or novel agents in an attempt to further improve outcomes while maintaining an effective, safe, and ideally outpatient regimen for MCL,” the authors wrote.

The approval for patients with acute myeloid leukemia was based on data from the phase 3 QUAZAR AML-001 trial, which demonstrated that patients who received Onureg achieved a median overall survival of 24.7 months compared to 14.8 months for those who received placebo.

A two-time cancer survivor discusses how survivors sometimes get assigned an unwilling task of being a cancer educator or ambassador to friends and family.

Each month, we take a look back at the most popular CURE® stories. Here are the top five stories for August 2020.

While the rare cancer landscape is growing, progress is happening thanks to patients advocating for their care.

On social media, CURE® recently asked its readers what their thoughts were on the medical use of cannabis. Here, we share some of their responses.

A roundup of the latest news and updates for patients with acute myeloid leukemia from CURE®.

CURE® compiled a roundup of five recent reports patients with lymphoma may have missed.

Feeling overwhelmed and scared during cancer treatment is completely normal. Here are some tips to help patients conquer their fears each step of the way.

Arzerra will be available at no cost to patients via an oncology patient access program which will be facilitated through Patient Access Novartis Oncology.

Chadwick Boseman, known best for his role in “Black Panther,” has died after receiving a colon cancer diagnosis four years ago.

Eryaspase, a novel drug candidate, is being evaluated in patients with second-line metastatic pancreatic cancer and those with metastatic triple-negative breast cancer.

Nearly half (48%) of the patients reported experiencing significant fatigue following their surgery. Thirty-nine percent of the patients still reported significant fatigue one year following their surgery.

A former clinical trial designer at the National Cancer Institute offers patients with cancer advice on why they should consider joining clinical trials and provides insight into two common misconceptions about trials.

From Washington Football Team head coach Ron Rivera announcing he has cancer but plans to continue coaching this season, to ”Dancing With the Stars” judge Len Goodman revealing he had surgery to remove skin cancer from his face, here’s what’s happening in the cancer landscape this week.

In addition to improving progression-free survival, researchers have found single-agent Ninlaro (ixazomib) to be a tolerable option in patients with newly diagnosed multiple myeloma who have also already undergone an autologous stem cell transplant.

The novel next-generation ALK tyrosine kinase inhibitor improved survival, compared with Xalkori, in patients with ALK-positive non-small cell lung cancer, potentially representing a new option in the first-line setting.

This easy and healthy mango smoothie bowl recipe from the oncology dietitians at the John Theurer Cancer Center is sure to add some life to your breakfast when you get bored of your tried and true go-to’s.

I am not pining for the end of the pandemic, which makes me a bit of a weirdo among people I know, even though the end of the pandemic would be wonderful. I have been changed as a result of my cancer diagnosis, for it taught me that things can change at any moment.

The test was also approved as a companion diagnostic test to determine which select patients with metastatic castration-resistant prostate cancer could benefit from Rubraca, as well as for three frontline TKIs in patients with non-small cell lung cancer.

Here is a list of the recent trial initiations that occurred within the cancer space in August.

Often uncovered by accident, appendiceal cancers trigger few symptoms until they’re advanced and can be difficult to detect and treat.